Heron Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Heron Therapeutics, Inc.‘s stocks are currently a part of 188 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 118.16M shares of Heron Therapeutics, Inc.. Compared to the previous quarter, the number fell by -0.24% or -289.73K shares fewer. As for the holding position changes, 40.96% (77) of current hedge fund investors increased the number of shares held, 26.6% (50) of current holders sold a part of the shares held, and 19.15% (36) closed the holdings completely. 20 hedge funds are new holders of Heron Therapeutics, Inc. stock in Q1 2022, it is 10.64% of total holders.
Hedge funds holding Heron Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 104 |
|---|---|
| Q3 2017 | 104 |
| Q4 2017 | 125 |
| Q1 2018 | 152 |
| Q2 2018 | 196 |
| Q3 2018 | 193 |
| Q4 2018 | 174 |
| Q1 2019 | 195 |
| Q2 2019 | 175 |
| Q3 2019 | 179 |
| Q4 2019 | 200 |
| Q1 2020 | 194 |
| Q2 2020 | 191 |
| Q3 2020 | 183 |
| Q4 2020 | 191 |
| Q1 2021 | 196 |
| Q2 2021 | 194 |
| Q3 2021 | 201 |
| Q4 2021 | 206 |
| Q1 2022 | 188 |
Hedge funds changes in Heron Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 17 | 46 | 25 | 11 | 5 |
|---|---|---|---|---|---|
| Q3 2017 | 14 | 35 | 31 | 12 | 12 |
| Q4 2017 | 30 | 47 | 29 | 9 | 10 |
| Q1 2018 | 46 | 54 | 40 | 19 | -7 |
| Q2 2018 | 57 | 65 | 56 | 11 | 7 |
| Q3 2018 | 31 | 77 | 62 | 34 | -11 |
| Q4 2018 | 23 | 69 | 60 | 42 | -20 |
| Q1 2019 | 33 | 77 | 51 | 11 | 23 |
| Q2 2019 | 25 | 76 | 49 | 42 | -17 |
| Q3 2019 | 28 | 75 | 40 | 23 | 13 |
| Q4 2019 | 45 | 78 | 51 | 16 | 10 |
| Q1 2020 | 37 | 81 | 53 | 39 | -16 |
| Q2 2020 | 37 | 71 | 54 | 39 | -10 |
| Q3 2020 | 21 | 63 | 66 | 29 | 4 |
| Q4 2020 | 27 | 55 | 68 | 21 | 20 |
| Q1 2021 | 29 | 69 | 67 | 23 | 8 |
| Q2 2021 | 37 | 66 | 50 | 38 | 3 |
| Q3 2021 | 24 | 74 | 51 | 14 | 38 |
| Q4 2021 | 32 | 68 | 61 | 26 | 19 |
| Q1 2022 | 20 | 77 | 50 | 36 | 5 |
Hedge funds changes in Heron Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 23,548,000 | 1,111,000 |
|---|---|---|
| Q3 2017 | 12,145,000 | 1,584,000 |
| Q4 2017 | 14,264,000 | 3,316,000 |
| Q1 2018 | 39,366,000 | 35,742,000 |
| Q2 2018 | 41,566,000 | 106,592,000 |
| Q3 2018 | 22,429,000 | 6,674,000 |
| Q4 2018 | 7,299,000 | 1,003,969,000 |
| Q1 2019 | 45,057,000 | 8,191,000 |
| Q2 2019 | 7,203,000 | 6,805,000 |
| Q3 2019 | 8,619,000 | 5,824,000 |
| Q4 2019 | 4,928,000 | 4,797,000 |
| Q1 2020 | 5,867,000 | 9,658,000 |
| Q2 2020 | 5,019,000 | 6,174,000 |
| Q3 2020 | 1,011,000 | 1,076,000 |
| Q4 2020 | 2,937,000 | 1,200,000 |
| Q1 2021 | 19,845,000 | 3,989,000 |
| Q2 2021 | 6,243,000 | 3,780,000 |
| Q3 2021 | 3,564,000 | 1,506,000 |
| Q4 2021 | 12,504,000 | 10,366,000 |
| Q1 2022 | 7,752,000 | 2,567,000 |